Skip to content
10-K

Annual Report

IDEXX LABORATORIES INC /DE IDXX

0000874716-25-000037

← back to feed
Filed
Feb 21, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 12, 2025 81.33M sh
Long Term Debt FY 2024 · Dec 31, 2023 $622.88M
Short Term Debt FY 2024 · Dec 31, 2023 $75M
Cash And Equivalents FY 2024 · Dec 31, 2023 $453.93M
Current Liabilities FY 2024 · Dec 31, 2023 $951.55M
Total Liabilities FY 2024 · Dec 31, 2023 $1.78B
Current Assets FY 2024 · Dec 31, 2023 $1.5B
Total Assets FY 2024 · Dec 31, 2023 $3.26B
Shares Diluted FY 2024 · Dec 31, 2022 84.6M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $819.71M
Capex FY 2024 · Dec 31, 2022 $148.84M
Operating Cash Flow FY 2024 · Dec 31, 2022 $542.98M
Eps Diluted FY 2024 · Dec 31, 2022 $8.03
Eps Basic FY 2024 · Dec 31, 2022 $8.12
Sga Expense FY 2024 · Dec 31, 2022 $326.25M
Rd Expense FY 2024 · Dec 31, 2022 $254.82M
Net Income FY 2024 · Dec 31, 2022 $679.09M
Operating Income FY 2024 · Dec 31, 2022 $898.77M
Gross Profit FY 2024 · Dec 31, 2022 $2B
Revenue FY 2024 · Dec 31, 2022 $3.37B
Stockholders Equity FY 2024 · Dec 31, 2021 $689.99M